NO940710L - Nye Esculetin-derivater og farmasöytisk blanding - Google Patents
Nye Esculetin-derivater og farmasöytisk blandingInfo
- Publication number
- NO940710L NO940710L NO940710A NO940710A NO940710L NO 940710 L NO940710 L NO 940710L NO 940710 A NO940710 A NO 940710A NO 940710 A NO940710 A NO 940710A NO 940710 L NO940710 L NO 940710L
- Authority
- NO
- Norway
- Prior art keywords
- hydrogen atom
- new
- group
- independently
- general formula
- Prior art date
Links
- ILEDWLMCKZNDJK-UHFFFAOYSA-N esculetin Chemical class C1=CC(=O)OC2=C1C=C(O)C(O)=C2 ILEDWLMCKZNDJK-UHFFFAOYSA-N 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 4
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- -1 linolyl Chemical group 0.000 abstract 2
- YQTCQNIPQMJNTI-UHFFFAOYSA-N 2,2-dimethylpropan-1-one Chemical group CC(C)(C)[C]=O YQTCQNIPQMJNTI-UHFFFAOYSA-N 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000001931 aliphatic group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 125000000400 lauroyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 abstract 1
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 125000003696 stearoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
- A61K31/37—Coumarins, e.g. psoralen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
Abstract
Farmasøytisk blanding som inneholder en forbindelse med den generelle formel (I): R2O d) hvori R1 og R2 uavhengig av hverandre, er et hydrogenatom, en mettet eller umettet alifatisk acylgruppe med fra 2 til 25 karbonatomer eller en benzoylgruppe, og R3 er et hydrogenatom eller en alkylgruppe, foruten et farmasøytisk akseptabelt fortynningsmiddel. Videre er det beskrevet en ny forbindelse med den generelle formel (I) hvor R1 og R2 uavhengig av hveran- dre er et hydrogenatom, en pivaloyl-, kapryloyl, lauroyl-, palmitoyl-, stearoyl-, linolyl-, dokosaheksaenoyl- eller benzoylgruppe, og R3 er et hydrogenatom eller en metylgruppe.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6616493 | 1993-03-02 | ||
| JP5351659A JPH06312925A (ja) | 1993-03-02 | 1993-12-27 | 軟骨保護剤及び新規エスクレチン誘導体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO940710D0 NO940710D0 (no) | 1994-03-01 |
| NO940710L true NO940710L (no) | 1994-09-05 |
Family
ID=26407334
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO940710A NO940710L (no) | 1993-03-02 | 1994-03-01 | Nye Esculetin-derivater og farmasöytisk blanding |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5455268A (no) |
| EP (1) | EP0614896B1 (no) |
| JP (1) | JPH06312925A (no) |
| KR (1) | KR0135723B1 (no) |
| CN (1) | CN1147297C (no) |
| AU (1) | AU660870B2 (no) |
| CA (1) | CA2116617C (no) |
| DE (1) | DE69415570T2 (no) |
| NO (1) | NO940710L (no) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4323409A1 (de) * | 1993-07-13 | 1995-01-19 | Boehringer Mannheim Gmbh | Verwendung von Cumarinen und Carbostyrilen als PLA¶2¶-Inhibitoren, neue Cumarine und Carbostyrile, Verfahren zu ihrer Herstellung und Arzneimittel |
| DE69423424T2 (de) * | 1993-11-15 | 2006-08-10 | Kureha Corp. | Esculetinderivate, Verfahren zu deren Herstellung und deren Verwendung als pharmazeutische Zusammensetzungen |
| JP2902318B2 (ja) * | 1994-12-28 | 1999-06-07 | 呉羽化学工業株式会社 | エスクレチン誘導体、その製造方法及びマトリックスメタロプロテアーゼ阻害剤 |
| GB9609024D0 (en) * | 1996-05-01 | 1996-07-03 | Idg Uk Ltd | Compounds |
| WO1998004572A1 (en) * | 1996-07-31 | 1998-02-05 | Kureha Chemical Industry Co., Ltd. | Novel coumarin derivatives and glycosides thereof, and processes for the preparation of both |
| US6368817B1 (en) | 1997-06-04 | 2002-04-09 | Newcastle Upon Tyne Hospitals National Health Service Trust | Identification of salmonella |
| JP2000119181A (ja) | 1998-10-06 | 2000-04-25 | Kureha Chem Ind Co Ltd | エスクレチン及びその誘導体の放出制御経口製剤 |
| US7067144B2 (en) * | 1998-10-20 | 2006-06-27 | Omeros Corporation | Compositions and methods for systemic inhibition of cartilage degradation |
| CN1186336C (zh) * | 2002-08-29 | 2005-01-26 | 成都迪康药物研究所 | 秦皮总香豆素的制备方法及其在制药中的应用 |
| WO2005091960A2 (en) * | 2004-03-05 | 2005-10-06 | Rush University Medical Center | Method for inhibiting fibrocartilage degradation |
| CN100428934C (zh) * | 2006-09-07 | 2008-10-29 | 中国人民解放军第二军医大学 | 香豆素类化合物在制备诱导神经干细胞定向分化药物中的应用 |
| CN104557831B (zh) * | 2015-02-11 | 2016-03-23 | 施维雅(青岛)生物制药有限公司 | 七叶内酯衍生物及其制备方法和应用 |
| CN119606945B (zh) * | 2025-02-11 | 2025-05-06 | 广州白云山星群(药业)股份有限公司 | 夏桑菊潜在活性成分4-甲基七叶亭在制备防治糖尿病药物中的应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2276819A1 (fr) * | 1974-07-05 | 1976-01-30 | Fabre Sa Pierre | Facteurs p lipophile a action anti-inflammatoire locale utilisables dans le traitement de syndromes dermatologiques |
-
1993
- 1993-12-27 JP JP5351659A patent/JPH06312925A/ja active Pending
-
1994
- 1994-02-28 CA CA002116617A patent/CA2116617C/en not_active Expired - Fee Related
- 1994-02-28 KR KR1019940003709A patent/KR0135723B1/ko not_active Expired - Fee Related
- 1994-03-01 EP EP94103036A patent/EP0614896B1/en not_active Expired - Lifetime
- 1994-03-01 NO NO940710A patent/NO940710L/no unknown
- 1994-03-01 AU AU56438/94A patent/AU660870B2/en not_active Ceased
- 1994-03-01 DE DE69415570T patent/DE69415570T2/de not_active Expired - Fee Related
- 1994-03-02 US US08/204,445 patent/US5455268A/en not_active Expired - Lifetime
- 1994-03-02 CN CNB941022374A patent/CN1147297C/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0614896B1 (en) | 1998-12-30 |
| CA2116617A1 (en) | 1994-09-03 |
| DE69415570T2 (de) | 1999-06-24 |
| JPH06312925A (ja) | 1994-11-08 |
| AU5643894A (en) | 1994-09-15 |
| KR0135723B1 (ko) | 1998-04-23 |
| AU660870B2 (en) | 1995-07-06 |
| KR940021058A (ko) | 1994-10-17 |
| DE69415570D1 (de) | 1999-02-11 |
| CN1147297C (zh) | 2004-04-28 |
| NO940710D0 (no) | 1994-03-01 |
| US5455268A (en) | 1995-10-03 |
| CN1101259A (zh) | 1995-04-12 |
| CA2116617C (en) | 2001-02-20 |
| EP0614896A1 (en) | 1994-09-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO940710L (no) | Nye Esculetin-derivater og farmasöytisk blanding | |
| HUT36840A (en) | Process for producing 11-beta-estradiene derivatives and pharmaceutical compositions containing them | |
| NO942110D0 (no) | Lipopeptider fra Actinoplanes sp. med farmakologisk virkning fremgangsmåte for fremstilling og anvendelse derav | |
| ES8504211A1 (es) | Procedimiento para la preparacion de derivados de oligoglucosido | |
| KR850004472A (ko) | 4h-3,i-벤즈옥사진-4-온 유도체의 제조방법 | |
| HUT37631A (en) | Process for producing 6,6-ethylene-15,16-methylene-3-oxo.17-alpha-pregn-4-ene-21,17-carbolavtones and pharmaceutical compositions containing them | |
| NO944926L (no) | Fremgangsmåter for å inhibere myeloperoksidaseaktivitet | |
| IL83141A (en) | Solutions of oxazophosphorins having improved stability and their preparation | |
| TR199802297T2 (xx) | Eritromisin t�revlerinin 10-metil radikallerinin izomerizasyonu i�in yeni y�ntem. | |
| SE8501613D0 (sv) | Foreningar for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutisk behandling | |
| HU906230D0 (en) | Process for the preparation of benzanilide derivatives and medical preparations containing them | |
| HUT50845A (en) | Process for producing 14,17beta-ethano-14beta-estratrienes and pharmaceutical compositions comprising same | |
| CA1267150C (en) | THIABICYCLOHEPTANE SUBSTITUTION DERIVATIVES OF AMINO-PROSTAGLANDIN ANALOGS | |
| ES8502700A1 (es) | Procedimiento para la fabricacion de derivados de tetrahidrobenzotiazol. | |
| FR2485000B1 (no) | ||
| ES483798A1 (es) | Un procedimiento para la preparacion de nuevos derivados de hidantoina | |
| NO974747L (no) | Fremgangsmåte for fremstilling av streptograminer | |
| NO973103L (no) | Fremgangsmåte for inhibering av veksthormoneffekter | |
| HUT71618A (en) | Process to prepare acid anhydrides | |
| IL67324A0 (en) | New dehydrocardenolide derivatives,process for the preparation thereof and pharmaceutical preparations containing the same | |
| DK0431151T3 (da) | Fremgangsmåde til fremstilling af 21-brom-4-pregnen-3,20-dion-derivater |